Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Millot, F" or (type any "bookEditor issueEditor" and editor="Millot, F")

Add to list
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

C Piette, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, G Plat, N Dastugue, F Mazingue, et al.

(2018) LEUKEMIA. 32(1). p.244-248
Add to list
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Chrildren's Leukemia Group study 58951

E Clappier, N Grardel, M Bakkus, J Rapion, Barbara De Moerloose (UGent) , P Kastner, A Caye, J Vivent, V Costa, A Ferster, et al.

(2015) LEUKEMIA. 29(11). p.2154-2161
Add to list
- Conference Paper
- C3
Presentation and outcome of children with down syndrome and acute lymphoblastic leukemia in the eortc children's leukemia group protocol 58951

Veerle Mondelaers (UGent) , Barbara De Moerloose (UGent) , S Suciu, A Ferster, P Lutz, A Uyttebroeck, D Plantaz, L Norton, N Sirvent, A Robert, et al.

(2010) HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 95(Suppl. 2). p.260-260
Add to list
- Conference Paper
- C3
Prognostic significance of blasts with/without pleiocytosis in the cerebro-spinal fluid (CSF) of children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) children leukemia group study 58881

N Sirvent, S Suciu, X Rialland, A Robert, F Mazingue, F Millot, Barbara De Moerloose (UGent) , A Ferster, P Rohrlich, L Norton, et al.

(2006) Blood. 108(11). p.A149-A149
Add to list
- Journal Article
- A1
Treatment outcome in infant acute lymphoblastic leukemia.

A FERSTER, Yves Benoit (UGent) , N FRANCOTTE, MF DRESSE, A UYTTEBROECK, E PLOUVIER, A THYSS, P LUTZ, G MARGUERITE, C BEHAR, et al.

(2000) BLOOD. 95(8). p.2729-2730
Add to list
- Journal Article
- A1
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III Trial.

F MILLOT, S SUCIU, N PHILIPPE, Yves Benoit (UGent) , F MAZINGUE, A UYTTEBROECK, P LUTZ, F MECHINAUD, A ROBERT, P BOUTARD, et al.

(2000) JOURNAL OF CLINICAL ONCOLOGY. 19(7). p.1935-1942
Add to list
- Journal Article
- A1
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report.

E VILMER, S SUCIU, A FERSTER, Y BERTRAND, H CAVÉ, A THYSS, Yves Benoit (UGent) , N DASTUGUE, M FOURNIER, G SOUILLET, et al.

(2000) LEUKEMIA. 14(12). p.2257-2266
Add to list
- Journal Article
- A1
Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma

F Millot, A Robert, Y Bertrand, F Mechinaud, Genevieve Laureys (UGent) , A Ferster, P Brock, P Rohrlich, F Mazingue, D Plantaz, et al.

(1997) PEDIATRICS. 100(1). p.60-64
Add to list
- Conference Paper
- C3
Specific cutaneous infiltrates in children with acute lymphoblastic leukemia or lymphoblastic lymphoma

F MILLOT, A ROBERT, Y BERTRAND, F MECHINAUD, Genevieve Laureys (UGent) , A FERSTER, P BROCK, P RORLICH, F MAZINGUE, D PLANTZ, et al.

(1995) BLOOD. 86(10). p.694-694

Academic Bibliography

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Chrildren's Leukemia Group study 58951

Presentation and outcome of children with down syndrome and acute lymphoblastic leukemia in the eortc children's leukemia group protocol 58951

Prognostic significance of blasts with/without pleiocytosis in the cerebro-spinal fluid (CSF) of children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) children leukemia group study 58881

Treatment outcome in infant acute lymphoblastic leukemia.

Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: Results of the European Organization for Research and Treatment of Cancer 58881 Randomized Phase III Trial.

Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report.

Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma

Specific cutaneous infiltrates in children with acute lymphoblastic leukemia or lymphoblastic lymphoma

Contents

Support

Contact